Emil Kongshøj Larsen

Executive Vice President, International Operations · Novo Nordisk

Pharmaceuticals

Emil Kongshøj Larsen leads Novo Nordisk’s international operations after regional commercial management and earlier policy-advisory work.

Last reviewed: Nov 15, 2026

Executive Summary

Emil Kongshøj Larsen leads Novo Nordisk’s international operations after regional commercial management and earlier policy-advisory work.

Career Highlights

  • Joined Novo Nordisk in 2007 following work in Danish and European parliamentary policy.
  • Led North West Europe and then Europe and Canada.
  • Succeeded Mike Doustdar in International Operations in August 2025.

Professional Journey

Larsen worked as a policy adviser in the Danish and European Parliaments before joining Novo Nordisk in 2007. His policy work covered economic issues, healthcare and tax reform, following a political-science master’s degree at the University of Copenhagen in 2002.

Within Novo Nordisk, he held commercial affairs and strategy responsibilities in International Operations and led businesses across Africa, the Middle and Near East, and the Commonwealth of Independent States. These assignments preceded his move into the company’s European regional leadership.

In 2022, Larsen became senior vice president for North West Europe, covering fifteen countries. A 2024 restructuring expanded his remit to Europe and Canada, a forty-country region. Novo Nordisk’s subsequent succession announcement described that region as accounting for approximately one fifth of global sales at the time.

He became executive vice president for International Operations in August 2025, succeeding Mike Doustdar as Doustdar moved to the CEO role. Based in Zurich, Larsen oversees the company’s commercial operations outside the United States. His remit combines the regional businesses he previously led with the wider international commercial organisation.

Education

  • University of Copenhagen — M.A., Political Science.